• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症诱发的心肌病的发病率、预后及危险因素。

Incidence, prognosis, and risk factors of sepsis-induced cardiomyopathy.

作者信息

Liang Yan-Wen, Zhu You-Feng, Zhang Rui, Zhang Min, Ye Xiao-Ling, Wei Jian-Rui

机构信息

Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Guangzhou 510220, Guangdong Province, China.

Department of Geriatrics, The Affiliated Hospital of Qingdao University, Qingdao 270000, Shandong Province, China.

出版信息

World J Clin Cases. 2021 Nov 6;9(31):9452-9468. doi: 10.12998/wjcc.v9.i31.9452.

DOI:10.12998/wjcc.v9.i31.9452
PMID:34877280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8610866/
Abstract

BACKGROUND

At present, large-scale studies on the clinical characteristics of sepsis-induced cardiomyopathy (SIC) are lacking.

AIM

To investigate the clinical characteristics of SIC.

METHODS

Based on the analysis of the MIMIC-III public database, we performed a large-scale retrospective study involving sepsis patients who were admitted to the intensive care unit (ICU) and had no concomitant cardiac disease. We used propensity score matching analysis and multivariate logistic regression to ensure the robustness of the results. The primary outcome was hospital mortality, and the secondary outcomes included the number of patients who received mechanical ventilation or renal replacement therapy during their hospital stay, the number of patients administered with vasopressors, the length of ICU stay, and the length of hospital stay.

RESULTS

In the present study, after screening 38605 patients, 3530 patients with sepsis were included. A total of 997 patients met the SIC diagnostic criteria, and the incidence of SIC was 28.20% (95% confidence interval [CI]: 26.80%-29.70%). Compared to patients in the non-SIC group, patients in the SIC group were of older age and had a higher Simplified Acute Physiology Score (SAPS)-I score, SAPS-II score, and Elixhauser comorbidity index (ECI). A total of 367 (36.8%) of 997 patients in the SIC group and 818 (32.3%) of 2533 patients in the non-SIC group died in the hospital, which resulted in a significant between-group difference (odds ratios = 1.22, 95%CI: 1.05-1.42; = 0.011). For the secondary outcomes, more patients in the SIC group received mechanical ventilation and vasopressors. Multivariate logistic regression analysis showed that age, male sex, ECI, hemoglobin level, diabetes, and mechanical ventilation use on the first day of ICU admission were risk factors for SIC.

CONCLUSION

Compared with non-SIC patients, hospital mortality is higher in SIC patients.

摘要

背景

目前,关于脓毒症诱导的心肌病(SIC)临床特征的大规模研究尚缺乏。

目的

探讨SIC的临床特征。

方法

基于对MIMIC-III公共数据库的分析,我们进行了一项大规模回顾性研究,纳入入住重症监护病房(ICU)且无合并心脏病的脓毒症患者。我们采用倾向评分匹配分析和多因素逻辑回归以确保结果的稳健性。主要结局为住院死亡率,次要结局包括住院期间接受机械通气或肾脏替代治疗的患者数量、使用血管升压药的患者数量、ICU住院时长及住院时长。

结果

在本研究中,经筛选38605例患者后,纳入3530例脓毒症患者。共有997例患者符合SIC诊断标准,SIC发病率为28.20%(95%置信区间[CI]:26.80% - 29.70%)。与非SIC组患者相比,SIC组患者年龄更大,且简化急性生理学评分(SAPS)-I、SAPS-II评分及埃利克斯豪泽合并症指数(ECI)更高。SIC组997例患者中有367例(36.8%)、非SIC组2533例患者中有818例(32.3%)在医院死亡,组间差异有统计学意义(比值比 = 1.22,95%CI:1.05 - 1.42;P = 0.011)。对于次要结局,SIC组更多患者接受了机械通气和血管升压药治疗。多因素逻辑回归分析显示,年龄、男性、ECI、血红蛋白水平、糖尿病及入住ICU首日使用机械通气是SIC的危险因素。

结论

与非SIC患者相比,SIC患者的住院死亡率更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1939/8610866/133021a3f999/WJCC-9-9452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1939/8610866/35eb9963c40d/WJCC-9-9452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1939/8610866/133021a3f999/WJCC-9-9452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1939/8610866/35eb9963c40d/WJCC-9-9452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1939/8610866/133021a3f999/WJCC-9-9452-g002.jpg

相似文献

1
Incidence, prognosis, and risk factors of sepsis-induced cardiomyopathy.脓毒症诱发的心肌病的发病率、预后及危险因素。
World J Clin Cases. 2021 Nov 6;9(31):9452-9468. doi: 10.12998/wjcc.v9.i31.9452.
2
Development of a Nomogram to Predict 28-Day Mortality of Patients With Sepsis-Induced Coagulopathy: An Analysis of the MIMIC-III Database.预测脓毒症诱导的凝血病患者28天死亡率的列线图的开发:MIMIC-III数据库分析
Front Med (Lausanne). 2021 Apr 6;8:661710. doi: 10.3389/fmed.2021.661710. eCollection 2021.
3
[Clinical characteristics and prognosis of acute kidney injury in elderly patients with sepsis].[老年脓毒症患者急性肾损伤的临床特征与预后]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jul;31(7):837-841. doi: 10.3760/cma.j.issn.2095-4352.2019.07.008.
4
The relationship between dexmedetomidine administration and prognosis in patients with sepsis-induced coagulopathy: a retrospective cohort study.右美托咪定给药与脓毒症诱导的凝血病患者预后的关系:一项回顾性队列研究。
Front Pharmacol. 2024 Jul 23;15:1414809. doi: 10.3389/fphar.2024.1414809. eCollection 2024.
5
Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sepsis-Induced Coagulopathy: A Retrospective Analysis of MIMIC-III Database.普通肝素抗凝治疗脓毒症诱导的凝血病的良好结局:MIMIC-III数据库的回顾性分析
Front Med (Lausanne). 2022 Jan 3;8:773339. doi: 10.3389/fmed.2021.773339. eCollection 2021.
6
[Monocyte/lymphocyte ratio as a predictor of 30-day mortality and adverse events in critically ill patients: analysis of the MIMIC-III database].[单核细胞/淋巴细胞比值作为危重症患者30天死亡率和不良事件的预测指标:MIMIC-III数据库分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 May;33(5):582-586. doi: 10.3760/cma.j.cn121430-20201223-00772.
7
[Efficacy and safety of stress ulcer prophylaxis in septic patients: a retrospective cohort study based on large database].[脓毒症患者应激性溃疡预防的疗效与安全性:基于大型数据库的回顾性队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jun;33(6):641-647. doi: 10.3760/cma.j.cn121430-20210402-00504.
8
Sepsis-induced cardiomyopathy is associated with higher mortality rates in patients with sepsis.脓毒症诱发的心肌病与脓毒症患者较高的死亡率相关。
Acute Crit Care. 2021 Aug;36(3):215-222. doi: 10.4266/acc.2021.00234. Epub 2021 Jul 26.
9
[Predictive value of glycemic variability within 6 hours on the short-term prognosis of patients with septic shock].[脓毒性休克患者6小时内血糖变异性对短期预后的预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jan;33(1):28-32. doi: 10.3760/cma.j.cn121430-20200410-00274.
10
[Early incidence and prognosis of ICU-acquired weakness in mechanical ventilation patients].[机械通气患者ICU获得性肌无力的早期发病率及预后]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jul;31(7):821-826. doi: 10.3760/cma.j.issn.2095-4352.2019.07.005.

引用本文的文献

1
Characterisation of Post-Sepsis Cardiomyopathy Using Cardiovascular Magnetic Resonance.利用心血管磁共振成像对脓毒症后心肌病的特征描述
Diagnostics (Basel). 2025 Apr 14;15(8):997. doi: 10.3390/diagnostics15080997.
2
Prognostic analysis of sepsis-induced myocardial injury patients using propensity score matching and doubly robust analysis with machine learning-based risk prediction model development.使用倾向评分匹配和双重稳健分析以及基于机器学习的风险预测模型开发对脓毒症诱导的心肌损伤患者进行预后分析。
Front Med (Lausanne). 2025 Feb 19;12:1555103. doi: 10.3389/fmed.2025.1555103. eCollection 2025.
3
Sepsis-Induced Cardiomyopathy Secondary to Escherichia coli Sepsis and Intestinal Perforation: A Diagnostic Challenge in a Paediatric Patient.

本文引用的文献

1
Sepsis-Induced Cardiomyopathy: a Comprehensive Review.脓毒症相关性心肌病:全面综述。
Curr Cardiol Rep. 2020 May 6;22(5):35. doi: 10.1007/s11886-020-01277-2.
2
Sepsis induced cardiomyopathy: Pathophysiology and use of mechanical circulatory support for refractory shock.脓毒症诱导的心肌病:病理生理学及机械循环支持在难治性休克中的应用
J Crit Care. 2019 Dec;54:228-234. doi: 10.1016/j.jcrc.2019.09.001. Epub 2019 Sep 12.
3
Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study.
大肠杆菌败血症和肠穿孔继发的败血症性心肌病:一名儿科患者的诊断挑战
Cureus. 2024 Dec 29;16(12):e76552. doi: 10.7759/cureus.76552. eCollection 2024 Dec.
4
The Effect of Hybrid Blood Purification Combined with Ulinastatin for the Treatment of Severe Sepsis on APACHE II Score and Levels of miR-146a and miR-155.混合血液净化联合乌司他丁治疗严重脓毒症对APACHE II评分及miR-146a和miR-155水平的影响
Int J Gen Med. 2024 Dec 8;17:5897-5905. doi: 10.2147/IJGM.S491193. eCollection 2024.
5
Diagnostic and Prognostic Value of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) for Septic Cardiomyopathy.髓系细胞触发受体-1(sTREM-1)对脓毒症性心肌病的诊断和预后价值
J Inflamm Res. 2024 Oct 29;17:7869-7879. doi: 10.2147/JIR.S481792. eCollection 2024.
6
Analysis of the Relevant Vital Signs and Infection of Sepsis Patients and to Explore the Influencing Factors of Acute Lung Injury/Acute Respiratory Distress Syndrome.脓毒症患者相关生命体征及感染情况分析并探讨急性肺损伤/急性呼吸窘迫综合征的影响因素
Contrast Media Mol Imaging. 2022 Sep 2;2022:7718248. doi: 10.1155/2022/7718248. eCollection 2022.
7
Clinical implications of septic cardiomyopathy: A narrative review.脓毒症性心肌病的临床意义:一篇叙述性综述。
Medicine (Baltimore). 2024 Apr 26;103(17):e37940. doi: 10.1097/MD.0000000000037940.
8
Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report.体外膜肺氧合治疗曲霉菌感染所致脓毒性心肌病:首例病例报告
Infect Drug Resist. 2024 Mar 30;17:1303-1307. doi: 10.2147/IDR.S449491. eCollection 2024.
9
Prediction model of death risk in patients with sepsis and screening of biomarkers for prognosis of patients with myocardial injury.脓毒症患者死亡风险预测模型及心肌损伤患者预后生物标志物的筛选
Heliyon. 2024 Feb 29;10(5):e27209. doi: 10.1016/j.heliyon.2024.e27209. eCollection 2024 Mar 15.
10
Testosterone and soluble ST2 as mortality predictive biomarkers in male patients with sepsis-induced cardiomyopathy.睾酮和可溶性ST2作为脓毒症诱导型心肌病男性患者死亡率的预测生物标志物
Front Med (Lausanne). 2024 Jan 8;10:1278879. doi: 10.3389/fmed.2023.1278879. eCollection 2023.
老年及高龄重症脓毒症患者死亡的危险因素:一项前瞻性、观察性、多中心队列研究。
Ann Intensive Care. 2019 Feb 4;9(1):26. doi: 10.1186/s13613-019-0495-x.
4
The role of mitochondria in sepsis-induced cardiomyopathy.线粒体在脓毒症性心肌病中的作用。
Biochim Biophys Acta Mol Basis Dis. 2019 Apr 1;1865(4):759-773. doi: 10.1016/j.bbadis.2018.10.011. Epub 2018 Oct 17.
5
Risk factors for sepsis morbidity in a rural hospital population: A case-control study.农村医院人群脓毒症发病风险因素的病例对照研究。
Am J Infect Control. 2018 Sep;46(9):1041-1046. doi: 10.1016/j.ajic.2018.02.011. Epub 2018 Mar 30.
6
A systematic review on risk factors associated with sepsis in patients admitted to intensive care units.一项关于 ICU 收治患者发生脓毒症的相关危险因素的系统评价。
Aust Crit Care. 2019 Mar;32(2):155-164. doi: 10.1016/j.aucc.2018.02.005. Epub 2018 Mar 21.
7
Thioredoxin-1 attenuates sepsis-induced cardiomyopathy after cecal ligation and puncture in mice.硫氧还蛋白-1可减轻小鼠盲肠结扎和穿刺术后脓毒症诱导的心肌病。
J Surg Res. 2017 Dec;220:68-78. doi: 10.1016/j.jss.2017.06.062. Epub 2017 Jul 25.
8
Incidence and evolution of sepsis-induced cardiomyopathy in a cohort of patients with sepsis and septic shock.脓毒症和脓毒性休克患者队列中脓毒症诱导的心肌病的发病率和演变情况。
Med Intensiva (Engl Ed). 2018 Jun-Jul;42(5):283-291. doi: 10.1016/j.medin.2017.08.008. Epub 2017 Nov 1.
9
Sepsis-Induced Cardiomyopathy: Oxidative Implications in the Initiation and Resolution of the Damage.脓毒症相关性心肌病:损伤起始和修复过程中的氧化作用。
Oxid Med Cell Longev. 2017;2017:7393525. doi: 10.1155/2017/7393525. Epub 2017 Sep 19.
10
The MIMIC Code Repository: enabling reproducibility in critical care research.MIMIC 代码库:实现重症监护研究的可重复性。
J Am Med Inform Assoc. 2018 Jan 1;25(1):32-39. doi: 10.1093/jamia/ocx084.